Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Demyelinating disorders
ADR ID BADD_A01193
ADR Hierarchy
17      Nervous system disorders
17.16      Demyelinating disorders
Description Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system. | The first region-restricted episode of CNS inflammatory demyelination in a patient. It is usually characterized by an acute monosymptomatic presentation of the optic nerves, brainstem, or spinal cord. It may not reoccur (isolated), or it may progress to MULTIPLE SCLEROSIS. [MeSH]
MedDRA Code 10012303
MeSH ID D003711
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Demyelinating Diseases | Demyelinating Disease | Demyelinating Disorders | Demyelinating Disorder | Demyelination | Demyelinations | Clinically Isolated Syndrome, CNS Demyelinating | Clinically Isolated CNS Demyelinating Syndrome
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D00041Adalimumab
BADD_D00062Aldesleukin
BADD_D00064Alemtuzumab
BADD_D00066Alendronic acid
BADD_D00076Allopurinol
BADD_D00085Alprazolam
BADD_D00151Apixaban
BADD_D00156Apremilast
BADD_D00165Aripiprazole
BADD_D00194Azacitidine
BADD_D00195Azathioprine
BADD_D00209Baclofen
BADD_D00223Belatacept
BADD_D00230Bendamustine
BADD_D00284Bortezomib
BADD_D00285Bosentan
BADD_D00291Brentuximab vedotin
BADD_D00306Budesonide
BADD_D00310Buprenorphine
BADD_D00349Capecitabine
BADD_D00356Carbamazepine
BADD_D00424Cevimeline
BADD_D00425Cevimeline hydrochloride
BADD_D00429Chlorambucil
BADD_D00475Citalopram
BADD_D00479Cladribine
BADD_D00480Clarithromycin
BADD_D00501Clonazepam
BADD_D00511Clozapine
BADD_D00526Conivaptan
The 1th Page    1 2 3 4 5    Next   Last    Total 5 Pages